-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Tenax Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Tenax Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $3.96M, a 101% increase year-over-year.
- Tenax Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $4.84M, a 63.3% decline year-over-year.
- Tenax Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $7.71M, a 30.2% decline from 2022.
- Tenax Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $11M.
- Tenax Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$32.5M, a 230% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)